New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1094-1101

  Genth, Harald ^a   Selzer, Jörg ^a   Busch, Christian ^a   Dumbach, Jürgen ^a   Hofmann, Fred ^a   Aktories, Klaus ^a   Just, Ingo ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; ANTIGEN; ANTITOXIN; CLOSTRIDIUM DIFFICILE TOXIN B; FORMALDEHYDE; URIDINE DIPHOSPHATE; URIDINE DIPHOSPHATE GLUCOSE;

ALKYLATION; ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ARTICLE; CLOSTRIDIUM DIFFICILE; CYTOTOXICITY; DETOXIFICATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PSEUDOMEMBRANOUS COLITIS; TOXIN STRUCTURE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; BINDING SITES; CLOSTRIDIUM DIFFICILE; HELA CELLS; HUMANS; IMMUNE SERA; IMMUNIZATION; RABBITS; URIDINE DIPHOSPHATE;

EID: 0033976505     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1094-1101.2000     Document Type: Article

References (46)

1. Aktories, K., S. Rösener, U. Blaschke, and G. S. Chhatwal. 1988. Botulinum ADP-ribosyltransferase C3. Purification of the enzyme and characterization of the ADP-ribosylation reaction in platelet membranes. Eur. J. Biochem. 172:445-450.
2. Allo, M., J. Silva, R. Fekety, G. D. Rifkin, and H. Waskin. 1979. Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin. Gastroenterology 76:351-355.
3. Barroso, L. A., S.-Z. Wang, C. J. Phelps, J. L. Johnson, and T. D. Wilkins. 1990. Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res. 18:4004.
4. Bette, P., A. Oksche, F. Mauler, C. Von Eichel-Streiber, M. R. Popoff, and E. Habermann. 1991. A comparative biochemical, pharmacological and immunological study of Clostridium novyi α-toxin, C. difficile toxin B and C. sordellii lethal toxin. Toxicon 29:877-887.
5. Busch, C., F. Hofmann, J. Selzer, J. Munro, D. Jeckel, and K. Aktories. 1998. A common motif of eukaryotic glycosyltransferases is essential for the enzyme activity of large clostridial cytotoxins. J. Biol. Chem. 273:19566-19572.
6. Chaves-Olarte, E., P. Löw, E. Freer, T. Norlin, M. Weidmann, C. Von Eichel-Streiber, and M. Thelestam. 1999. A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins. J. Biol. Chem. 274:11046-11052.
7. Ciesielski-Treska, J., G. Ulrich, O. Baldacini, H. Monteil, and D. Aunis. 1991. Phosphorylation of cellular proteins in response to treatment with Clostridium difficile toxin B and Clostridium sordellii toxin L. Eur. J. Cell Biol. 56:68-78.
8. Cropley, I., G. Douce, M. Roberts, S. Chatfield, M. Pizza, I. Marsili, R. Rappuoli, and G. Dougan. 1995. Mucosal and systemic immunogenicity of a recombinant, non ADP-ribosylating pertussis toxin: effects of formaldehyde treatment. Vaccine 13:1643-1648.
9. Dove, C. H., S. Z. Wang, S. B. Price, C. J. Phelps, D. M. Lyerly, T. D. Wilkins, and J. L. Johnson. 1990. Molecular characterization of the Clostridium difficile toxin A gene. Infect. Immun. 58:480-488.
10. Faust, C., B. Ye, and K.-P. Song. 1998. The enzymatic domain of Clostridium difficile toxin A is located within its N-terminal region. Biochem. Biophys. Res. Commun. 251:100-105.
11. Fiorentini, C., G. Arancia, S. Paradisi, G. Donelli, M. Giuliano, F. Piemonto, and P. Mastrantonio. 1989. Effects of Clostridium difficile toxins A and B on cytoskeleton organization in HEp-2 cells: a comparative morphological study. Toxicon 27:1209-1218.
12. Fiorentini, C., and M. Thelestam. 1991. Clostridium difficile toxin A and its effects on cells. Toxicon 29:543-567.
13. Genth, H., F. Hofmann, J. Selzer, G. Rex, K. Aktories, and I. Just. 1996. Difference in protein substrate specificity between hemorrhagic toxin and lethal toxin from Clostridium sordellii. Biochem. Biophys. Res. Commun. 229:370-374.
14. Green, G. A., V. Schué, and H. Monteil. 1995. Cloning and characterization of the cytotoxin L-encoding gene of Clostridium sordellii: homology with Clostridium difficile cytotoxin B. Gene 161:57-61.
15. Hatheway, C. L. 1990. Toxigenic clostridia. Clin. Microbiol. Rev. 3:66-98.
16. Hofmann, F., C. Busch, U. Prepens, I. Just, and K. Aktories. 1997. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J. Biol. Chem. 272:11074-11078.
17. Hofmann, F., G. Rex, K. Aktories, and I. Just. 1996. The Ras-related protein RaI is monoglucosylated by Clostridium sordellii lethal toxin. Biochem. Biophys. Res. Commun. 227:77-81.
18. Just, I., J. Selzer, F. Hofmann, and K. Aktories. 1997. Clostridium difficile toxin B as a probe for Rho GTPases, p. 159-168. In K. Aktories (ed.), Bacterial toxins - tools in cell biology and pharmacology. Chapman & Hall, Weinheim, Germany.
19. Just, I., J. Selzer, F. Hofmann, G. A. Green, and K. Aktories. 1996. Inactivation of Ras by Clostridium sordellii lethal toxin-catalyzed glucosylation. J. Biol. Chem. 271:10149-10153.
20. Just, I., J. Selzer, M. Wilm, C. Von Eichel-Streiber, M. Mann, and K. Aktories. 1995. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375:500-503.
21. Just, I., M. Wilm, J. Selzer, G. Rex, C. Von Eichel-Streiber, M. Mann, and K. Aktories. 1995. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem. 270:13932-13936.
22. 2 generation and histamine release from isolated rat peritoneal mast cells. Biochem. Biophys. Res. Commun. 143:467-474.
23. Kelly, C. P., and J. T. LaMont. 1998. Clostridium difficile infection. Annu. Rev. Med. 49:375-390.
24. Kelly, C. P., C. Pothonlakis, and J. T. LaMont. 1994. Clostridium difficile colitis. N. Engl. J. Med. 330:257-262.
25. Killeen, K. P., V. Escuyer, J. J. Mekalanos, and R.J. Collier. 1992. Reversion of recombinant toxoids: mutations in diphtheria toxin that partially compensate for active-site deletions. Proc. Natl. Acad. Sci. USA 89:6207-6209.
26. Kink, J. A., and J. A. Williams. 1998. Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection. Infect. Immun. 66:2018-2025.
27. Krivan, H. C., G. F. Clark, D. F. Smith, and T. D. Wilkins. 1986. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Galα1-3Galβ1-4GlcNAc. Infect. Immun. 53: 573-581.
28. Larson, H. E., and A. B. Proce. 1977. Pseudomembranous colitis; presence of clostridial toxin. Lancet ii:1312-1314.
29. London, E. 1992. Diphtheria toxin: membrane interaction and membrane translocation. Biochim. Biophys. Acta 1113:25-51.
30. Lyerly, D. M., C. J. Phelps, J. Toth, and T. D. Wilkins. 1986. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect. Immun. 54:70-76.
31. Lyerly, D. M., and T. D. Wilkins. 1995. Clostridium difficile, p. 867-891. In M. J. Blaser, P. D. Smith, J. I. Ravdin, H. B. Greenberg, and R. L. Guerrant (ed.), Infections of the gastrointestinal tract. Raven Press, Ltd., New York, N.Y.
32. Martiny-Baron, G., M. Mehrabian, and H. G. Martinson. 1981. Contact-site cross-linking agents. Mol. Cell. Biochem. 34:3-13.
33. Ohishi, I., M. Iwasaki, and G. Sakaguchi. 1980. Purification and characterization of two components of botulinum C2 toxin. Infect. Immun. 30:668-673.
34. Pizza, M., M. Domenighini, W. Hol, V. Gianelli, M. R. Fontana, M. M. Giuliani, C. Magagnoli, S. Peppolini, R. Manetti, and R. Rappuoli. 1994. Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis. Mol. Microbiol. 14:51-60.
35. Pizza, M., M. R. Fontana, M. M. Giuliani, M. Domenighini, C. Magagnoli, V. Gianelli, D. Nucci, W. Hol, R. Manetti, and R. Rappuoli. 1994. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. J. Exp. Med. 180:2147-2153.
36. Popoff, M. R., O. E. Chaves, E. Lemichez, C. Von Eichel-Streiber, M. Thelestam, P. Chardin, D. Cussac, P. Chavrier, G. Flatau, M. Giry, J. Gunzburg, and P. Boquet. 1996. Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. J. Biol. Chem. 271:10217-10224.
37. Powell, J. T., and K. Brew. 1976. Affinity labeling of bovine colostrum galactosyltransferase with a uridine 5′-diphosphate derivative. Biochemistry 15:3499-3505.
38. Rifkin, G. D., F. R. Fekety, J. Silva, and R. B. Sack. 1977. Antibiotic-induced colitis. Implication of a toxin neutralised by Clostridium sordellii antitoxin. Lancet ii:1103-1106.
39. Schmidt, M., M. Vo, M. Thiel, B. Bauer, A. Grannass, E. Tapp, R. H. Cool, J. De Gunzburg, C. Von Eichel-Streiber, and K. H. Jakobs. 1998. Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordellii lethal toxin and Clostridium difficile toxin B-1470 in HEK-293 cells. J. Biol. Chem. 273:7413-7422.
40. Selzer, J., F. Hofmann, G. Rex, M. Wilm, M. Mann, I. Just, and K. Aktories. 1996. Clostridium novyi α-toxin-catalyzed incorporation of GlcNAc into Rho subfamily proteins. J. Biol. Chem. 271:25173-25177.
41. Torres, J. F., D. M. Lyerly, and T. P. Monath. 1995. Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters. Infect. Immun. 63:4619-4627.
42. Torres, J. F., and T. P. Monath. 1996. Antigenicity of amino-acid sequences from Clostridium difficile toxin B. J. Med. Microbiol. 44:464-474.
43. Von Eichel-Streiber, C., D. M. Z. Heringdorf, E. Habermann, and S. Sartingen. 1995. Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B. Mol. Microbiol. 17:313-321.
44. Von Eichel-Streiber, C., R. Laufenberg-Feldmann, S. Sartingen, J. Schulze, and M. Sauerborn. 1992. Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol. Gen. Genet. 233:260-268.
45. Ward, S. J., G. Douce, G. Dougan, and B. W. Wren. 1999. Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficile. Infect. Immun. 67:5124-5132.
46. Yadav, S., and K. Brew. 1990. Identification of a region of UDP-galactose: N-acetylglucosamine β4-galactosyltransferase involved in UDP-galactose binding by differential labeling. J. Biol. Chem. 265:14163-14169.